Expanded Access Study With Peginterferon Alfa-2a (Pegasys) in Participants With Chronic Myelogenous Leukemia (CML)
Condition: Myelogenous Leukemia, ChronicIntervention: Drug: Peginterferon alfa-2aSponsor: Hoffmann-La RocheCompleted - verified April 2016
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials